p53 Localizes to the centrosomes and spindles of mitotic cells in the embryonic chick epiblast, human cell lines, and a human primary culture: An immunofluorescence study

Experimental Cell Research

Volumn 256, Issue 1, 2000, Pages 122-130

  Morris, Valerie B ^a   Brammall, Jennifer ^a   Noble, Jane ^a   Reddel, Roger ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cancer cells; Cell cycle; Immunocytochemistry; Mitotic spindle; p53 protein; Tubulin

Indexed keywords

TUBULIN;

ANIMAL CELL; ARTICLE; CENTROSOME; CHICK EMBRYO; CONTROLLED STUDY; CYTOKINESIS; ECTODERM; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MITOSIS SPINDLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION;

ANIMALIA; VERTEBRATA;

EID: 0034630156     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4800     Document Type: Article

References (43)

1. Levine A. J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
2. Lane D. P., Crawford L. V. T antigen is bound to a host protein in SV40-transformed cells. Nature. 278:1979;261-263.
3. Lane D. P. Awakening angels. Nature. 394:1998;616-617.
4. 2 arrest after DNA damage. Science. 282:1998;1497-1501.
5. Cross S. M., Sanchez C. A., Morgan C. A., Schimke M. K., Ramel S., Idzerda R. L., Raskind W. H., Reid B. J. A p53-dependent mouse spindle checkpoint. Science. 267:1995;1353-1356.
6. Di Leonardo A., Khan S. H., Linke S. P., Greco V., Seidita G., Wahl G. M. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res. 57:1997;1013-1019.
7. Lanni J. S., Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18:1998;1055-1064.
8. Notterman D., Young S., Wainger B., Levine A. J. Prevention of mammalian DNA reduplication, following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activity. Oncogene. 17:1998;2743-2751.
9. Fukasawa K., Choi T., Kuriyama R., Rulong S., Vande Woude G. F. Abnormal centrosome amplification in the absence of p53. Science. 271:1996;1744-1747.
10. Schmid P., Lorenz A., Hameister H., Montenarh M. Expression of p53 during mouse embryogenesis. Development. 113:1991;857-865.
11. Hall P. A., Lane D. P. Tumour suppressors: A developing role for p53. Curr. Biol. 7:1997;R144-R147.
12. Wallingford J. B., Seufert D. W., Virta V. C., Vize P. D. p53 activity is essential for normal development in Xenopus. Curr. Biol. 7:1997;747-757.
13. Choi J., Donehower L. A. p53 in embryonic development: Maintaining a fine balance. Cell. Mol. Life Sci. 55:1999;38-47.
14. Morris V. B., Cowan R. An analysis of the growth of the retinal cell population in embryonic chicks yielding proliferative ratios, numbers of proliferative and non-proliferative cells and cell-cycle times for successive generations of cell cycles. Cell Prolif. 28:1995;373-391.
15. Hamburger V., Hamilton M. L. A series of normal stages in the development of the chick embryo. J. Morphol. 88:1951;49-67.
16. Reddel R. R., Ke Y., Gerwin B. I., McMenamin M. G., Lechner J. F., Su R. T., Brash D. E., Park J.-B., Rhim J. S., Harris C. C. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48:1988;1904-1909.
17. Pulciani S., Santos E., Lauver A. V., Long L. K., Aaronson S. A., Barbacid M. Oncogenes in solid tumours. Nature. 300:1982;539-542.
18. Nigro J. M., Baker S. J., Preisinger A. C., Jessup J. M., Hostetter R., Cleary K., Bigner S. H., Davidson N., Baylin S., Devilee P., Glover T., Collins F. S., Weston A., Modali R., Harris C. C., Vogelstein B. Mutations in the p53 gene occur in diverse human tumour types. Nature. 342:1989;705-708.
19. Lehman T. A., Bennett W. P., Metcalf R. A., Welsh J. A., Ecker J., Modali R. V., Ullrich S., Romano J. W., Appella E., Testa J. R., Gerwin B. I., Harris C. C. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res. 51:1991;4090-4096.
20. Reddel R. R., De Silva R., Duncan E. L., Rogan E. M., Whitaker N. J., Zahra D. G., Ke Y., McMenamin M. G., Gerwin B. I., Harris C. C. SV40-induced immortalization and ras-transformation of human bronchial epithelial cells. Int. J. Cancer. 61:1995;199-205.
21. Vojtěšek B., Bártek J., Midgley C. A., Lane D. P. An immunochemical analysis of the human nuclear phosphoprotein p53: New monoclonal antibodies and epitope mapping using recombinant p53. J. Immunol. Methods. 151:1992;237-244.
22. Bártek J., Bártková J., Lukáš J., Stašková Z., Vojtěšek B., Lane D. P. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies. J. Pathol. 169:1993;27-34.
23. Gannon J. V., Greaves R., Iggo R., Lane D. P. Activating mutations in p53 produce a common conformational effect: A monoclonal antibody specific for the mutant form. EMBO J. 9:1990;1595-1602.
24. Harlow E., Crawford L. V., Pim D. C., Williamson N. M. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39:1981;861-869.
25. Ball R. K., Siegl B., Quellhorst S., Brandner G., Braun D. G. Monoclonal antibodies against simian virus 40 nuclear large T tumour antigen: Epitope mapping, papova virus cross-reaction and cell surface staining. EMBO J. 3:1984;1485-1491.
26. Gurney E. G., Tamowski S., Deppert W. Antigenic binding sites of monoclonal antibodies specific for simian virus 40 large T antigen. J. Virol. 57:1986;1168-1172.
27. Lacey E., Snowdon K. L. Isolation of mammalian brain tubulin by amino-activated gel chromatography. J. Chromatog. 525:1990;71-84.
28. cdc2 kinase is localized to distinct domains within the mitotic apparatus. Cell Motil. Cytoskeleton. 17:1990;227-235.
29. Stephen C. W., Helminen P., Lane D. P. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: Insights into antibody-peptide interactions. J. Mol. Biol. 248:1995;58-78.
30. Soussi T., Bègue A., Kress M., Stehelin D., May P. Nucleotide sequence of a cDNA encoding the chicken p53 nuclear oncoprotein. Nucleic Acids Res. 16:1988;11383.
31. Maxwell S. A., Ames S. K., Sawai E. T., Decker G. L., Cook R. G., Butel J. S. Simian virus 40 large T antigen and p53 are microtubule-associated proteins in transformed cells. Cell Growth Differ. 2:1991;115-127.
32. Christen R. D., Jekunen A. P., Jones J. A., Thiebaut F., Shalinsky D. R., Howell S. B. In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules. J. Clin. Invest. 92:1993;431-440.
33. Brown C. R., Doxsey S. J., White E., Welch W. J. Both viral (adenovirus E1B) and cellular (hsp70, p53) components interact with centrosomes. J. Cell. Physiol. 160:1994;47-60.
34. Sakaguchi K., Sakamoto H., Xie D., Erickson J. W., Lewis M. S., Anderson C. W., Appella E. Effect of phosphorylation on tetramerization of the tumor suppressor protein p53. J. Protein Chem. 16:1997;553-556.
35. Shaulsky G., Goldfinger N., Tosky M. S., Levine A. J., Rotter V. Nuclear localization is essential for the activity of p53 protein. Oncogene. 6:1991;2055-2065.
36. cdc2 phosphorylation sites in NuMA impair the assembly of the mitotic spindle and block mitosis. J. Cell Sci. 108:1995;621-633.
37. Wang Y., Prives C. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature. 376:1995;88-91.
38. Milner J., Watson J. V. Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein. Oncogene. 5:1990;1683-1690.
39. Li F., Ambrosini G., Chu E. Y., Plescia J., Tognin S., Marchisio P. C., Altieri D. C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 396:1998;580-584.
40. Ambrosini G., Adida C., Altieri D. C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med. 3:1997;917-921.
41. Bischoff J. R., Friedman P. N., Marshak D. R., Prives C., Beach D. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc. Natl. Acad. Sci. USA. 87:1990;4766-4770.
42. cdc2. Oncogene. 16:1998;105-111.
43. Lengauer C., Kinzler K. W., Vogelstein B. Genetic instabilities in human cancers. Nature. 396:1998;643-649.